Jean F. Voltaire

Array ( [id] => 5436317 [patent_doc_number] => 20090170904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Substituted benzimidazoles and methods of their use' [patent_app_type] => utility [patent_app_number] => 12/315779 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 39821 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170904.pdf [firstpage_image] =>[orig_patent_app_number] => 12315779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514328 [patent_doc_number] => 20090214634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLADDER CANCER' [patent_app_type] => utility [patent_app_number] => 12/324019 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8162 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214634.pdf [firstpage_image] =>[orig_patent_app_number] => 12324019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153730 [patent_doc_number] => 08586636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Disulfide chemotherapeutic agents and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/743682 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6348 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5278097 [patent_doc_number] => 20090130229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Antitumor uses of compound' [patent_app_type] => utility [patent_app_number] => 12/313033 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4562 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130229.pdf [firstpage_image] =>[orig_patent_app_number] => 12313033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92382 [patent_doc_number] => 07732491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 12/269024 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44315 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732491.pdf [firstpage_image] =>[orig_patent_app_number] => 12269024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324387 [patent_doc_number] => 20090062377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'ANTI-CANCER COMBINATIONS' [patent_app_type] => utility [patent_app_number] => 12/264197 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6810 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062377.pdf [firstpage_image] =>[orig_patent_app_number] => 12264197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453253 [patent_doc_number] => 20090069290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Method for treating a demyelinating condition' [patent_app_type] => utility [patent_app_number] => 12/290423 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9953 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069290.pdf [firstpage_image] =>[orig_patent_app_number] => 12290423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423055 [patent_doc_number] => 20090149511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Administration of an Inhibitor of HDAC and an mTOR Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/260883 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27749 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149511.pdf [firstpage_image] =>[orig_patent_app_number] => 12260883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271109 [patent_doc_number] => 20090074885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Reversible Hydrophobic Modification of Drugs for Improved Delivery to Cells' [patent_app_type] => utility [patent_app_number] => 12/260679 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20117 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074885.pdf [firstpage_image] =>[orig_patent_app_number] => 12260679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436250 [patent_doc_number] => 20090170837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS FOR TREATING RAS DRIVEN CANCER IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 12/258102 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 44789 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170837.pdf [firstpage_image] =>[orig_patent_app_number] => 12258102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404613 [patent_doc_number] => 20090239927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Statin and Omega-3 Fatty Acids For Lipid Therapy' [patent_app_type] => utility [patent_app_number] => 12/256806 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8056 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239927.pdf [firstpage_image] =>[orig_patent_app_number] => 12256806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504012 [patent_doc_number] => 20100260753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'AMINOFLAVONE (NSC 686288) AND COMBINATIONS THEREOF FOR TREATING BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/739407 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4853 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260753.pdf [firstpage_image] =>[orig_patent_app_number] => 12739407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422962 [patent_doc_number] => 20090149417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors' [patent_app_type] => utility [patent_app_number] => 12/288329 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 57863 [patent_no_of_claims] => 248 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149417.pdf [firstpage_image] =>[orig_patent_app_number] => 12288329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410670 [patent_doc_number] => 20090124569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/250351 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20820 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124569.pdf [firstpage_image] =>[orig_patent_app_number] => 12250351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441808 [patent_doc_number] => 20090093447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'CDDO-COMPOUNDS AND COMBINATION THERAPIES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/249588 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 46284 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093447.pdf [firstpage_image] =>[orig_patent_app_number] => 12249588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515416 [patent_doc_number] => 08039488 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Methods and compositions for inhibition of angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/249847 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9322 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039488.pdf [firstpage_image] =>[orig_patent_app_number] => 12249847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183942 [patent_doc_number] => 08623874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Method of treating neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 12/202201 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4739 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12202201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853229 [patent_doc_number] => 20080318972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => '5-HT1A RECEPTOR SUBTYPE AGONIST' [patent_app_type] => utility [patent_app_number] => 12/202208 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4741 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318972.pdf [firstpage_image] =>[orig_patent_app_number] => 12202208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343328 [patent_doc_number] => 20090181978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => '5-HT1A RECEPTOR SUBTYPE AGONIST' [patent_app_type] => utility [patent_app_number] => 12/202192 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181978.pdf [firstpage_image] =>[orig_patent_app_number] => 12202192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055739 [patent_doc_number] => 20110112099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'THERAPEUTIC AGENT FOR CANCER RESISTANT TO PROTEASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/674230 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12243 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112099.pdf [firstpage_image] =>[orig_patent_app_number] => 12674230 [rel_patent_id] =>[rel_patent_doc_number] =>)